Glezer Stanislav 4
4 · Inogen Inc · Filed Dec 4, 2023
Insider Transaction Report
Form 4
Inogen IncINGN
Glezer Stanislav
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-12-01−769→ 5,380 total→ Common Stock (769 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-12-01−3,786→ 3,787 total→ Common Stock (3,786 underlying) - Exercise/Conversion
Common Stock
2023-12-01+4,555→ 12,146 total - Tax Payment
Common Stock
2023-12-01$5.72/sh−2,331$13,333→ 9,815 total
Footnotes (4)
- [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2023.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- [F3]Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.
- [F4]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.